Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

HEART 2024

Welcome Message

Conference Series warmly welcomes you to the “6th Euro Cardiology Congress which will be held on December 10-11, 2024 Dubai, UAE” with the theme Care for Your Heart: Stay Happy, Live Healthier”. The wide range of topics will give attendees a chance to learn about every aspect of Cardiology Health Care. The Delegates will be able to learn about the latest upgrades and exchange experiences with internationally renowned speakers at this gathering. All participants who are interested in contributing their research and data in the field of Cardiology and Health Care are invited.

HEART 2024 unites the worldwide pioneers who are involved in the Cardiology and Health Care field to explore their research work at the conference. Our Conference provides a great chance to collaborate with global business delegates and researchers and it is all set to be adorned by world renowned speakers. It's a unique stage for analysts to comprehend how it causes. 

About Conference

The “6th Euro Cardiology Congress" will take place from December 10-11, 2024 in Dubai, UAE following the theme Care for Your Heart: Stay Happy, Live Healthier. It encompasses a wide range of activities, including lectures, oral and poster presentations, exhibitions, panel discussions, and a wealth of knowledge sharing opportunities. This year's agenda offers you the chance to take part in or organize a Workshop in addition to innovative presentations and discussions.

The major goal of HEART 2024 is to bring together Cardiologists, Heart Specialist, Renowned speakers, Professors, Scientists, Educationalists, Researchers, Students and members of all Heart Health Care Associations and Universities  to exchange ideas and to provide them with a forum to exchange knowledge and discuss recent challenges and developments in the field of Cardiology Healthcare. The new forms of innovations and research are encouraged and provide an opportunity to the people who are attending the conference. It allows delegates to have issues addressed on Heart Health Care by recognized specialists who are up to date with the latest developments in the respective field and provide information on new techniques and technologies. You can share your research findings and gain recognition through certificates awarded by our esteemed world-class organizing committee.

Why to attend:

The Heart 2024 offers a unique platform for individuals globally to explore the nuances of emerging applications and specialties within the field. Through active participation in this event, attendees can engage with a diverse community of mental health professionals, share insights, and forge valuable partnerships with industry leaders and potential collaborators. Renowned speakers, state-of-the-art interventions, and the latest advancements in mental health highlight the importance of this conference as a premier forum for professional development and collaboration.

Target audience:

  • Cardiovascular Surgeons
  • Cardiologists
  • Interventional Cardiologists
  • Cardiology Fellows and Trainees
  • Cardiovascular Researchers
  • Nurses and Nurse Practitioners
  • Cardiology Technicians
  • Educators
  • Students
  • Primary Care Physicians
  • Cardiovascular Rehabilitation Specialists
  • Dietitians and Nutritionists
  • Allied Health Professionals
  • Medical Device Manufacturers
  • Pharmaceutical Companies
  • Public Health Officials and Advocacy Groups
  • Medical Educators
  • Health Technology Innovators
  • Healthcare professionals
  • Entrepreneurs and start-ups
  • Investors and mentors
  • International delegates

Sessions & Tracks

Track 1: Heart Regeneration

Heart regeneration refers to the natural or induced process by which damaged or injured heart tissue is repaired or replaced with healthy tissue, with the ultimate goal of restoring normal cardiac function. While the adult human heart has limited regenerative capacity compared to certain other tissues in the body, such as the liver or skin, there is ongoing research into various approaches to stimulate or enhance heart regeneration.

Track 2: Cardiovascular Diseases

Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels, leading to conditions such as heart attacks, strokes, and heart failure. They are among the leading causes of death globally, accounting for a significant proportion of mortality and morbidity worldwide. Most common among them are,

Track 3: Coronary Artery Diseases

Coronary artery disease (CAD) is a prevalent form of heart disease distinguished by the constriction or obstruction of the coronary arteries. These arteries are responsible for delivering oxygen-rich blood to the heart muscle. This restriction in blood flow can lead to various symptoms and complications, including angina (chest pain or discomfort), and heart failure.

Track 4: Diabetics, Obesity and Stroke

Diabetes and obesity are significant risk factors for stroke, a serious cardiovascular event that occurs when blood flow to the brain is disrupted, leading to brain cell damage or death. Preventing and managing stroke in individuals with diabetes and obesity require a comprehensive approach that addresses modifiable risk factors, promotes healthy lifestyle behaviours, and ensures optimal medical management of underlying conditions.

  • Hyperglycemia
  • Hypertension
  • Dyslipidaemia
  • Microvascular Complications

Track 5: Silent Ischemia and Ischemic Heart Disease

Silent ischemia and ischemic heart disease are related conditions characterized by inadequate blood supply to the heart muscle. While silent ischemia lacks overt symptoms, it still carries significant implications for cardiovascular health, highlighting the importance of early detection and management of underlying coronary artery disease. Ischemic heart disease, on the other hand, encompasses a spectrum of symptoms and clinical manifestations, requiring comprehensive evaluation and treatment to reduce the risk of adverse cardiovascular events.

  • Symptomatic Ischemic Heart Disease
  • Unstable Angina
  • Cardiogenic shock
  • Sudden Cardiac Death

Track 6: Congenital Heart Defect

A congenital heart defect (CHD) is a structural abnormality of the heart or the major blood vessels near the heart that is present at birth. These defects can vary widely in severity, from simple conditions with little or no effect on health to complex defects that require immediate medical intervention. Early detection, timely intervention, and ongoing medical care are essential for managing congenital heart defects effectively.

  • Septal Defects
  • Valvular Defects
  • Anomalies of the Great Arteries
  • Complex Congenital Heart Defects

Track 7: Treatment of Hole in the Heart

The treatment of a hole in the heart, also known as a septal defect, depends on the size, location, and severity of the defect, as well as the individual's age, overall health, and symptoms. The goal of treatment is to prevent complications associated with the hole in the heart, such as heart failure, pulmonary hypertension, or stroke, and to improve overall quality of life.

Track 8: Pediatric Cardiology

Pediatric cardiology plays a crucial role in the early detection, diagnosis, and treatment of heart conditions in children, ensuring that they receive the specialized care and support they need to thrive. Advances in medical technology, surgical techniques, and multidisciplinary care have significantly improved outcomes for children with heart conditions, allowing many to lead healthy and fulfilling lives.

Track 9: Heart Disease and Failure

Heart disease encompasses a range of conditions that affect the heart's structure and function, leading to impaired blood flow, reduced cardiac performance, and increased risk of complications such as heart failure. Early detection, timely intervention, and comprehensive care are essential for improving prognosis and reducing the risk of complications in individuals with heart disease and heart failure.

Track 10: Digital Cardiology

Digital cardiology refers to the integration of digital technologies, such as wearable devices, mobile health applications, telemedicine platforms, and artificial intelligence (AI), into the practice of cardiology to improve the prevention, diagnosis, treatment, and management of cardiovascular diseases. As digital technologies continue to evolve and become more integrated into healthcare delivery, digital cardiology will play an increasingly important role in modern cardiology practice.

  • Wearable Devices
  • Mobile Health Applications
  • Telemedicine Platforms
  • Artificial Intelligence (AI)

Track 11: Molecular and Nuclear Cardiology

Molecular and nuclear cardiology are specialized branches of cardiology that utilize advanced imaging techniques and molecular probes to diagnose, evaluate, and manage cardiovascular diseases at the molecular and cellular levels. These advanced imaging techniques offer valuable insights into the molecular mechanisms, pathophysiology, and functional abnormalities associated with various cardiovascular conditions, paving the way for personalized medicine approaches and targeted therapies in cardiology.

  • Molecular Imaging
  • Biomarker Analysis
  • Genomic and Proteomic Analysis
  • Myocardial Perfusion Imaging (MPI)

Track 12: Robotic Heart Surgery

Robotic heart surgery represents a significant advancement in cardiac surgery, offering patients the benefits of minimally invasive surgery, enhanced precision, and improved outcomes for a wide range of cardiac conditions. As technology continues to evolve, robotic-assisted techniques are expected to play an increasingly important role in the treatment of cardiovascular diseases.

Track 13: Cardiac Nursing

Cardiac nursing is a specialized field of nursing that focuses on the care of individuals with cardiovascular diseases and conditions. Cardiac nurses play a crucial role in the prevention, diagnosis, treatment, and management of cardiac disorders, as well as in promoting heart health and educating patients about cardiovascular risk factors and lifestyle modifications.

Track 14: Covid-19 effects of Heart Patients

The effects of COVID-19 on heart patients can be significant, particularly for those with underlying cardiovascular conditions. Individuals with heart disease should take precautions to reduce their risk of COVID-19 exposure, adhere to recommended preventive measures such as vaccination, mask-wearing, hand hygiene, and physical distancing, and continue to monitor and manage their cardiovascular health in collaboration with their healthcare providers.

  • Exacerbation of Cardiovascular Symptoms
  • Increased Risk of Thrombotic Events
  • Impact on Cardiac Rehabilitation and Care
  • Vaccination Considerations

Track 15: Women’s Cardiology

Women's cardiology emphasizes the importance of recognizing and addressing the unique aspects of heart disease in women to improve outcomes and reduce disparities in cardiovascular care. By understanding the differences in risk factors, symptoms, diagnosis, and treatment, healthcare providers can deliver personalized, evidence-based care to women with heart disease and promote heart health throughout the lifespan.

Track 16: Heart Rhythm and Arrhythmias

Heart rhythm, also known as cardiac rhythm, refers to the regular sequence of electrical impulses that coordinate the contraction and relaxation of the heart muscle, resulting in a normal heartbeat. An arrhythmia, on the other hand, is an abnormality in the heart's rhythm, characterized by irregular, too fast, or too slow heartbeats.

  • Bradycardia
  • Tachycardia
  • Atrial Fibrillation (AF)
  • Atrial Flutter

Track 17: Cardio Oncology

Cardio-oncology is a specialized field that focuses on the cardiovascular health of cancer patients, particularly those undergoing cancer treatment. It addresses the intersection between cancer therapies and their potential adverse effects on the heart and vasculature.

Track 18: Cardiovascular Surgeries

Cardiovascular surgeries encompass a range of procedures aimed at treating conditions affecting the heart and blood vessels. These surgeries require a highly skilled surgical team and often involve sophisticated technology and equipment. Advances in surgical techniques, imaging, and perioperative care have greatly improved outcomes for patients undergoing cardiovascular surgeries.

  • Coronary Artery Bypass Grafting (CABG)
  • Angioplasty and Stenting
  • Heart Valve Repair or Replacement
  • Heart Transplant

Track 19: Interventional Cardiology

Interventional cardiology is a branch of cardiology that deals with the diagnosis and treatment of cardiovascular diseases using minimally invasive procedures. These procedures are typically performed using catheters (thin, flexible tubes) inserted into blood vessels, often through small incisions in the skin. These offer advantages such as shorter recovery times, reduced risk of complications, and avoidance of open-heart surgery for many patients with cardiovascular conditions.

Track 20: Artificial Intelligence in Cardiology

Artificial intelligence holds great promise for transforming cardiology by enabling more accurate diagnosis, personalized treatment, proactive risk management, and efficient healthcare delivery. As AI continues to evolve and mature, its integration into clinical practice has the potential to revolutionize the way cardiovascular diseases are prevented, diagnosed, and treated, ultimately improving patient outcomes and quality of care.

Market Analysis

HEART 2024 stands as the premier gathering for esteemed scholars in cardiology, health specialists, analysts, educational scientists, industry researchers, and scientists to convene and exchange insights on advancements in the field. The primary aim of this conference is to foster the exchange of new ideas and research findings for treatment, while also assessing the current market landscape to chart the future trajectory of cardiac health. Emphasis will be placed on emerging technologies poised to revolutionize cardiac care, operational tools, and diagnostics, promising to shape the future of cardiac health care delivery.

Cardiac Monitoring and Cardiac Rhythm Management Market Size

The global cardiac monitoring and cardiac rhythm management market size was valued at USD 29.0 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.5% from 2020 to 2027. Rising incidence of cardiovascular disorders, treatment costs of cardiac diseases, increasing use of ambulatory and home services, favourable government regulation, and technological advancements are the vital drivers for this market for cardiac monitoring and cardiac rhythm management.

The COVID-19 outbreak caused due to SARS-CoV-2, already affected millions of people globally as of May 2020. The contagious coronavirus is also having an economic impact and implications on most of the sectors including the medical device industry. According to the World Economic Forum in March 2020, among the 500 people being hospitalized in the U.S., 20.0% were aged between 20 to 44 years and 18.0% were aged between 45-54 years.

Global AI in Cardiology Market

The Global AI in Cardiology Market was valued at the USD 1.5 Billion in 2023 and is projected to reach a substantial growth of the USD 40.5 Billion by 2033, with a CAGR of 39.4%. According to World Health Organization, 86.4% of people suffer from heart attacks and strokes, with an average death cases of the USD 17.9 million annually by virtue of cardiovascular diseases.

The market for AI in cardiology is broadly categorized into three segment, i.e., hardware, software and services components. Amongst these, software component is at the forefront of the global AI in cardiology market capturing a commendable market share of 61.3% in the year 2023. The segment further promises to showcase huge growth with the fastest CAGR of 36.4% during the foreseen period. The dominance of software component is as a result of soaring demand for AI based diagnostic solutions providing highly precise diagnosis for cardiac patients.

Related Conferences:

Heart diseases Conferences | Cardiology Conferences | Cardiology Research Conferences | World Heart Congress | Cardiology and Cardiovascular Diseases Conferences | World Heart and Brain Conference | Cardiology and Cardiac Surgery Conferences | Vascular Medicine Conferences | Heart Rhythm Conferences | Cardiology and Vascular Imaging Conferences | Interventional Cardiology Conferences | Hypertension and Healthcare Conferences

Related associations:

Indian Heart Association | World Heart Federation | ESC Affiliated Cardiac Societies | Cardiological Society of India | American Heart Association | Association of Clinical Cardiologists | Preventive Cardiovascular Nurses Association | The Heart Foundation | New York Heart Association | Philippine Heart Association

Related Journals:

Journal of the American Heart Association | Journal of Cardiovascular Nursing | Journal of Cardiac Failure | American Journal of Cardiology | Canadian Journal of Cardiology | International Journal of Cardiology | Journal of Cardiology | Journal of Cardiology and Cardiovascular Medicine | Journal of Cardiovascular Medicine | International Journal of Cardiology

Related societies:

Heart Rhythm Society | American Society of Preventive Cardiology | Canadian Cardiovascular Society | British Cardiovascular Intervention Society | Brunei Cardiac Society | Cardiological Society | American Society of Nuclear Cardiology | Heart Failure Society of America | British Cardiovascular Society | American Society of Echocardiography | The International Society of Cardiology


Past Conference Report

HEART 2023

The 6th Euro Cardiology Congress, hosted by Conference Series, convened on November 23-24, 2023, in Amsterdam, Netherlands, under the theme "Advancing Cardiac Research." This conference received widespread acclaim from attendees, thanks to its insightful discussions and notable keynote speakers representing prestigious institutions and universities. The event drew a diverse crowd, including budding researchers, industry professionals, and outstanding students from across the globe, enriching the discourse and ensuring its triumph.

We extend our heartfelt gratitude to the Organizing Committee, Keynote Speakers, and Moderators whose invaluable contributions were pivotal to the success of Heart 2023. With your steadfast support, we are committed to fostering collaboration among cardiac health researchers and experts worldwide. Your unwavering dedication has been fundamental in bringing this conference to fruition, and we eagerly anticipate expanding its impact with your continued involvement.

We also express our appreciation to the delegates, industry representatives, and esteemed individuals whose active participation facilitated stimulating discussions. Special recognition is extended to the Editorial Board Members of our Open Access Journals, Keynote Speakers, Honourable Guests, Distinguished Speakers, Students, Delegates, and Media Partners for their significant roles in promoting and enhancing the success of this event.

Let us meet again @HEART-2024

Once again, we extend a warm invitation to join us at the upcoming 6th Euro Cardiology Congress, set to take place in the picturesque city of Dubai, UAE, from December 10-11, 2024.

Join our team for the HEART 2024 and let's work together to make this gathering a resounding success amidst the enchanting setting of Dubai, UAE.

Visit: HEART 2024 for further details and to register

Contact us:

Program manager

Heart 2024

To Collaborate Scientific Professionals around the World

Conference Date December 10-11, 2024

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Clinical Investigation Interventional Cardiology Archives of Medicine

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


  • AI In Cardiology
  • Arrhythmias
  • Atherosclerosis
  • Biomarkers
  • Cardiac Biomaterials And Tissue Engineering
  • Cardiac Electrophysiology
  • Cardiac Health
  • Cardiac Imaging
  • Cardiac Imaging Modalities
  • Cardiac Interventions
  • Cardiac Nursing
  • Cardiac Rehabilitation
  • Cardiac Rehabilitation
  • Cardiac Research
  • Cardiac Risk Assessment Tools
  • Cardiac Stem Cell Therapy
  • Cardiac Surgery
  • Cardio Metabolic Diseases
  • Cardio-oncology
  • Cardiology Practice
  • Cardiomyopathy
  • Cardiovascular Diseases
  • Cardiovascular Epidemiology
  • Cardiovascular Genetics
  • Cardiovascular Pharmacology
  • Cardiovascular Risk Assessment
  • Cardiovascular Surgery Techniques
  • Clinical Trials
  • Congenital Heart Defects
  • Coronary Artery Disease
  • CPR Techniques
  • Defibrillators
  • Digital Health In Cardiology
  • Echocardiography
  • Electrophysiology
  • Genetics And Genomics In Cardiology
  • Heart Failure
  • Heart Health
  • Heart Rhythm Disorders
  • Heart Transplantation
  • Heart Valve Disease
  • Heart-lung Interactions
  • Hypertension
  • Imaging Modalities (e.g., MRI, CT Scan)
  • Inflammatory Heart Diseases
  • Innovations In Cardiology
  • Interventional Cardiology
  • Lifestyle Interventions
  • Monitoring In Cardiovascular Diseases
  • Novel Therapies In Cardiology
  • Pacemakers
  • Pediatric Cardiology
  • Peripheral Artery Disease
  • Prevention Strategies
  • Risk Factors
  • Structural Heart Disease
  • Structural Heart Interventions
  • Telemedicine For Cardiovascular Care
  • Thrombosis
  • Transcatheter Therapies
  • Vascular Biology